Patents show all

307Applications66Issued

Clinical Trials show all

1N/A

SEC Filings show all

8-K23610-Q5110-K17D2S-11

SEC Form D Funding Events

DateOfferedSoldType
2010-08-05$5,189,739$5,189,739Equity
2006-02-24UnknownUnknownOther (Paper Filing)

Key Executives

  • David J. Foster
    Executive Officer
  • Louis C. Bock
    Director
  • Charles W. Patrick
    Director
  • Lori F. Rafield
    Director
  • Patrick Plewman
    Executive Officer, Director
  • Bernard M. Alfano
    Executive Officer
  • Robert L. Wolfert
    Executive Officer
  • James P. Panek
    Director